share_log

Intra-Cellular Therapies | 8-K: INTRA-CELLULAR THERAPIES REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS, PROVIDES CORPORATE UPDATE AND RAISES 2024 CAPLYTA SALES GUIDANCE

Intra-Cellular Therapies | 8-K: INTRA-CELLULAR THERAPIES REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS, PROVIDES CORPORATE UPDATE AND RAISES 2024 CAPLYTA SALES GUIDANCE

Intra-Cellular Therapies | 8-K:細胞內療法公佈了2024年第二季度財務業績,提供了公司最新情況,並提高了2024年的CAPLYTA銷售指導
美股SEC公告 ·  08/07 07:51
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息